Intermediates
Anti Diabetic
| S.No | Product Name | CAS No |
|---|---|---|
| 1 | 6-Quinolineacetic acid | 5622-34-4 |
| 2 | 3-fluoro-1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,4-trifluorobut-1-yn-1-yl)-1H-indazole | 68986-76-5 |
| 3 | a-(R)-Cyclopentyl mandelic acid | 64471-45-0 |
| 4 | (R)-1-Methyl-3-pyrrolidinol | 104641-60-3 |
| 5 | 6-chloro-7-fluoro-indoline-2,3-dione | 942493-23-4 |
| 6 | 2-(2,3-dimethoxyphenyl)ethan-1-amine | 3213-29-4 |
| 7 | (1-Amino-2-methylpropan-2-yl)(methyl)amine | 116577-09-4 |
| 8 | 2-chloro-5-methyl-4-phenoxyaniline | 1552471-22-3 |
| 9 | 2-chloro-4-(2-fluorophenoxy)-5-methylaniline | 2680529-02-4 |
| 10 | 3-fl uoro-2-(trifl uoromethyl )benzon itrile | 261951-81-9 |
| 11 | (6-chloro-5-(cyclopropylcarbamoyl)pyridin-3-yl)boronic acid | --- |
| 12 | 1-(3-methyl-2-oxobutyl)-1H-imidazole-5-carbonitrile | 2018317-76-3 |
| 13 | 1-allyl-1H-imidazole-4-carbonitrile | --- |
| 14 | ethyl 5,6-dichloropicolinate | --- |
| 15 | 5-bromo-2-chloro-N-cyclopropylnicotinamide | --- |
| 16 | 5-bromo-2-chloro-N-cyclopropyl-N-methylnicotinamide | --- |
| 17 | 5-bromo-2-hydroxynicotinic acid | --- |
| 18 | 1H-imidazole-4-carbonitrile | 57090-88-7 |
| 19 | 3-cyclopropyl-2-fluorophenol | 2290421-25-7 |
| 20 | 2-(3,4-dihydroxy-5-(trifluoromethyl)phenyl)acetonitrile | |
| 21 | 2-chloro-6-(trifluoromethyl)benzaldehyde | 60611-22-5 |
| 22 | methyl 1-(3-chloropyridin-2-yl)-3-(hydroxymethyl)-1H-pyrazole-5-carboxylate | 960316-73-8 |
| 23 | methyl 3-oxocyclopentanecarboxylate | 32811-75-9 |
| 24 | 4-amino-3,6-dichloro-5-fluoropicolinic acid | 350601-54-6 |
| 25 | 4-(1,1,1,3,3,3-hexafluoropropan-2-yl)aniline | --- |
| 26 | methyl 5,6'-diamino-4'-bromo-4-chloro-2'-fluoro-3'-methoxy-[1,1'-biphenyl]-3-carboxylate | --- |
| 27 | 3-(bromomethyl)-2',4'-dichloro-2-fluoro-1,1'-biphenyl | 1361901-10-1 |
| 28 | 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)pyridine | --- |
| 29 | 1-(2-chloroethyl)-3-(4-fluorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | --- |
| 30 | 2-(7-(trifluoromethyl)benzo[d][1,3]dioxol-5-yl)acetonitrile | --- |
| 31 | 5-chloro-2-isopropylbenzaldehyde | 1289090-35-2 |
| 32 | 2-bromo-4-chloro-1-isopropylbenzene | --- |
| 33 | N-methyl-4-phenyl-1H-pyrazole-5-carboxamide | --- |
| 34 | 7-(methoxymethyl)-1,3-diazaspiro[4.4]nonane-2,4-dione | --- |
| 35 | 7-(ethoxymethyl)-1,3-diazaspiro[4.4]nonane-2,4-dione | --- |
| 36 | 1,4-dioxaspiro[4.4]nonan-7-ylmethanol | |
| 37 | 3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazine-4-carboxylic acid | |
| 38 | 2-(4-chloro-2,6-dimethylphenyl)acetic acid | 186748-50-5 |
| 39 | 4-(2-bromoacetyl)benzonitrile | 20099-89-2 |
| 40 | ((2R,6R)-6-methyl morpholin-2-yl)methanol | |
| 41 | Cyanotemozolomide (or) 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carbonitrile | 114601-31-9 |
| 42 | 5-isothiocyanato-3-(trifluoromethyl)picolinonitrile | 951753-87-0 |
| 43 | 7-methyl xanthine | 69-89-6 |
| 44 | bis ((penta chloro phenyl (thio (Zinc)) | 117-97-5 |
| 45 | (2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide | |
| 46 | tert-butyl 3-bromo-2-hydroxybenzylcarbamate | 2378271-30-6 |
| 47 | 3-(3-chloro-2-fluorophenoxy)-6-methylpyridazine-4-carboxylic acid | 2435607-79-5 |
| 48 | 4-(3-oxobutyl)phenyl acetate | 3572--06-3 |
| 49 | (S)-2-(1-phenylethoxy)acetic acid | 287400-90-2 |
| 50 | Bromo OTBN | 114772-54-2 |
| 51 | Methyl (2S)-3-(4-aminophenyl)-2-(2,6-di chloro benzamido)propionate | 554419-04-4 |
| 53 | 2-(2,3-dimethoxyphenyl)-N,N-dimethylethanamine | 3494--01-7 |
| 54 | 2,4-difluoro-3-(methylthio)benzoic acid | 169310-07-0 |
| 55 | 2-(2,4-difluoro-3-(methylthio)phenyl)-4,4-dimethyl-4,5-dihydrooxazole | ---- |
| 56 | 2-(4-fluoro-2-methyl-3-(methylthio)phenyl)-4,4-dimethyl-4,5-dihydrooxazole | ---- |
| 57 | 3-Carbamoyl-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium chloride | 23111-00-4 |
| 58 | Benzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl) -L-leucyl-L-phenylalaninate | 868540-15-2 |
| 103 | 2,3-bis(2-hydroxyethyl)phenol | 199391-75-8 |
| 104 | 2,3-dihydro-4-vinylbenzofuran | |
| 105 | 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene | 1030825-20-7 |
| 106 | 2-(4-Flurophenyl)Thiophene | 58861-48-6 |
| 113 | 2-chloro-4-(2,2,2-trichloroethyl)-3,3-dimethylcyclobutanone | |
| 114 | 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid | |
| 132 | 4-((1-Cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide | 915087-26-2 |
| 133 | 4-amino-2-fluoro-N-methylbenzamide | 915087-25-1 |
| 137 | 5-bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | 830346-48-0 |
| 138 | (S)-tert-butyl (2-(5-bromo-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6H)-yl)-1-phenylethyl)carbamate | |
| 139 | 3,6-dichloropyrazine-2-carbonitrile | 356783-16-9 |
| 140 | 3-amino-6-chloropyrazine-2-carbonitrile | |
| 141 | 5-chloropyrazin-2-amine | 33332-29-5 |
| 142 | 3-bromo-5-chloropyrazin-2-amine | 76537-18-3 |
| 143 | (S)-benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate | 1270093-99-6 |
| 144 | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | 1289646-93-0 |
| 145 | benzofuran-6-carboxylic acid | 77095-51-3 |
| 146 | (2RS)-2-(4-Chlorobenzoylamino)-3-(2-oxo-1,2-dihydroqunolin-4-yl)propanoic acid | 90098-04-7 |
| 147 | 2,3-dihydrobenzofuran-5-carbaldehyde | 55745-70-5 |
| 148 | (E)-ethyl 3-(2,3-dihydrobenzofuran-5-yl)acrylate | 196597-65-6 |
| 149 | (E)-2-(6,7-dihydro-1H-indeno[5,4-b]furan-8(2H)-ylidene)acetonitrile | 196597-79-2 |
| 150 | 6,7-dihydro-1H-indeno[5,4-b]furan-8(2H)-one | 196597-78-1 |
| 151 | 1-(6-Methylpyridin-3-yl)-2-[(4-methylsulfonyl)- phenyl] ethanone | 221615-75-4 |
| 152 | N-[(2Z)-2-Chloro-3-(dimethylamino)- 2-propenylidene]-N-methylmethanaminium hexafluorophosphate | 291756-76-8 |
| 153 | 1-(4-(Methylsulfonyl)phenyl) ethanone | 10297-73-1 |
| 154 | 2-(4-(Methylsulfonyl)phenyl) acetic acid | 104-01-8 |
| 155 | Methyl 6-methylnicotinate | 5470-70-2 |
| 160 | 6-cyclohexyl-4-methyl-2H-pyran-2-one | 14818-35-0 |
| 161 | 4-(3,5-Dichlorobenzamibo)-3-hydroxybenzoic acid | 1184581-58-5 |
| 162 | Methyl 2-amino-2-(2-chlorophenyl)acetate | 141109-13-9 |
| 163 | (S)-Methyl 2-amino-2-(2-chlorophenyl)acetate tartaric acid | 141109-15-1 |
| 164 | (S)-Methyl 2-amino-2-(2-chlorophenyl)acetate | 141109-14-0 |
| 165 | 2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate | 40412-06-4 |
| 166 | (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride | 141109-19-5 |
Anti Depressant/ Anti Psychotic
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Lurasidone Intermediates | (1R ,2R )-1,2-Cyclohexanedimethanol | 65376-05-8 |
| ((1R,2R)-2-{[Methyl Sulphonyl]methyl}Cyclohexyl)Methyl methane sulfoate | 66347-68-0 | ||
| (3aR ,4S ,7R ,7aS ) 4,7-Methano-1H -isoindole-1,3(2H )-dione | 14805-29-9 | ||
| (R,R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 | ||
| 2 | Vilazodone Intermediates | 3-(4-Chlorobutyl)-1H -indole-5-carbonitrile | 143612-79-7 |
| 5-Aminobenzofuran-2-carboxylic acid ethyl ester | 174775-48-5 | ||
| Ethyl5-(4-tert-butoxy-carbonyl-1-piperizinyl)benzofuran-2-carboxilate | 183288-43-9 | ||
| 3 | Escitalopram oxalate Intermediate | 4-[4-Dimethylamino)-1-(4-Fluorophenyl)-1-Hydroxybutyl]-3-(Hydroxymethyl) Benzonitrile | 103146-25-4 |
Anti Fungal
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Albaconazole Intermediates | 7-chloro-1H-quinazolin-4-one | 31374-18-2 |
| 2 | Efinaconazole Intermediates | 1-[[(2R, 3S)-2-(2, 4-Difluorophenyl)-3-methyloxiranyl] methyl]-1H-1, 2, 4- | 127000-90-2 |
| 4-methylene piperidine-HCl | 144230-50-2 | ||
| 3 | Isavuconazole Intermediates | 1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole | 241479-73-2 |
| (2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | 241479-74-3 | ||
| (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide Hydrate Hydrosulfate . | 368421-58-3 | ||
| 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile | 241479-67-4 |
Anti Histamine
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Bilastine Intermediates | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzol[d]imidazole | 110963-63-8 |
| 2-[4-(2-{4-[1(2-ethoxyethyl)-1H-1,3-benzodiazol-2-yl]piperidine-1-yl}ethyl)phenyl]-2-methylpropanoic acid | 202189-78-4 |
Anti Histamine
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Siponimod Intermediates | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | 1378888-43-7 |
| 3-Azetidinecarboxylic acid | 36476-78-5 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Linagliptin Intermediates | 2‐(Chloromethyl)‐4‐methylquinazoline | 109113‐72‐6 |
| 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione | 93703-24-3 | ||
| 8‐Bromo‐7‐(but‐2‐yn‐1‐yl)‐3‐methyl‐3,7‐dihydro‐1H‐purine‐2,6‐dione | 666816‐98‐4 | ||
| (R)‐3‐(Boc‐Amino)piperidine | 309956‐78‐3 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Lurasidone Intermediates | (1R,2R)‐1,2‐Cyclohexanedimethanol | 65376‐05‐8 |
| ((1R,2R)-2-{[Methyl Sulphonyl]methyl}Cyclohexyl)Methyl methane sulfoate | 66347-68-0 | ||
| (3aR,4S,7R,7aS) 4,7‐Methano‐1H‐isoindole‐1,3(2H)‐dione | 14805‐29‐9 | ||
| (R,R)‐1,2‐Bis(methanesulfonyloxymethyl)cyclohexane | 186204‐35‐3 | ||
| 2 | Vilazodone Intermediates | 3‐(4‐Chlorobutyl)‐1H‐indole‐5‐carbonitrile | 143612‐79‐7 |
| 5‐Aminobenzofuran‐2‐carboxylic acid ethyl ester | 174775‐48‐5 | ||
| Ethyl5‐(4‐tert‐butoxy‐carbonyl‐1‐piperizinyl)benzofuran‐2‐carboxilate | 183288‐43‐9 | ||
| 3 | Escitalopram Oxalate Intermediate | 4-[4-Dimethylamino)-1-(4-Fluorophenyl)-1-Hydroxybutyl]-3-(Hydroxymethyl)Benzonitrile | 103146-25-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Albaconazole Intermediates | 7‐chloro‐1H‐quinazolin‐4‐one | 31374‐18‐2 |
| 2 | Efinaconazole Intermediates | 1‐[[(2R,3S)‐2‐(2,4‐Difluorophenyl)‐3‐methyloxiranyl]methyl]‐1H‐1,2,4‐triazole | 127000‐90‐2 |
| 4‐methylene piperidine‐HCl | 144230‐50‐2 | ||
| 3 | Isavuconazole Intermediates | 1‐(((2R,3S)‐2‐(2,5‐difluorophenyl)‐3‐Methyloxiran‐2‐yl)Methyl)‐1H‐1,2,4‐triazole | 241479‐73‐2 |
| (2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | 241479-74-3 | ||
| (2R,3R)‐3‐(2,5‐Difluorophenyl)‐3‐hydroxy‐2‐Methyl‐4‐(1H‐1,2,4‐triazol‐1‐yl)thiobutyramide Hydrate Hydrosulfate | 368421‐58‐3 | ||
| 4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile | 241479-67-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Bilastine Intermediates | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzol[d]imidazole | 110963-63-8 |
| 2-[4-(2-{4-[1(2-ethoxyethyl)-1H-1,3-benzodiazol-2-yl]piperidine-1-yl}ethyl)phenyl]-2-methylpropanoic acid | 202189-78-4 |
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Siponimod Intermediates | 1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone | 1378888-43-7 |
| 3-Azetidinecarboxylic acid | 36476-78-5 |
| CATEGORY | S.NO | INTERMEDIATE NAME | CHEMICAL NAME | CAS NO. |
|---|---|---|---|---|
| Anti Hypercholesteromia | 1 | Bempedoic acid Intermediates | ethyl 7-bromo-2,2-dimethylheptanoate | 123469-92-1 |
| Analgesic | 1 | Tapentadol HCl Intermediates | (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine | 175591-22-7 |
| Neuropathic Heredofamilial Amyloidosis | 1 | Tafamidis Meglumine Intermediates | methyl 4-(3,5-dichlorobenzamido)-3-hydroxybenzoate | 1184581-58-5 |
| 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid | 594839-88-0 |
NOTE : The above intermediates are intended to be supplied solely for uses reasonably relating to the testing and development of information, for regulatory submmission, strictly accordingly to the section 107A of the Indian patent Act, 1970
| CATEGORY | S.NO | API / INTERMEDIATE | CHEMICAL NAME | CAS NO. |
|---|---|---|---|---|
| ANTI NEOPLASTIC AGENT | 1 | METHOTREXATE | 2,4-Diamino-6-(hydroxymethyl)pteridine hydrochloride | 73978-41-3 |
| Non-Ergot Dopamine Agonist | 1 | PRAMIPEXOLE | (R,S)-2,6 diamino-4,5,6,7-tetrahydrobenzothiazole | 104617-49-4 |
| ANTI EPILEPTIC | 1 | PERAMPANEL | 2-(2-cyanophenyl)acetic acid | 18698-99-2 |
| pyridin-2-yl acetic acid hydrochloride | 16179-97-8 |
VIRUPAKSHA ORGANICS LTD
Anti Hypercholesteromia
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Bempedoic acid Intermediates | ethyl 7-bromo-2,2- dimethylheptanoate | 123469-92-1 |
Analgesic
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Tapentadol HCl Intermediates | (2R"3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan- 1-amine | 175591-22-7 |
Neuropathic Heredofamilial amyloidosis
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | Tafamidis Meglumine Intermediates | methyl 4-(3,5-dichlorobenzamido)-3-hydroxybenzoate | 1184581-58-5 |
| 2-(3,5-dichlorophenyl)benzo [d] oxazole-6-carboxylic acid | 594839-88-0 |
NOTE : The above intermediates are intended to be supplied solely for uses reasonably relating to the testing and development of information, for regulatory submmission, strictly accordingly to the section 107A of the Indian patent Act, 1970
ANTI NEOPLASTIC AGENT
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | METHOTREXATE | 2,4-Diamino-6-(hydroxymethyl)pteridine hydrochloride, CAS: 73978-41-3 | 73978-41-3 |
Non-Ergot dopamine agonist
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | PRAMIPEXOLE | (R,S)-2,6 diamino-4,5,6,7-tetrahydrobenzothiazole | 104617-49-4 |
ANTI EPILEPTIC
| S.NO | API INTERMEDIATES | NAME OF COMPOUND | CAS NO. |
|---|---|---|---|
| 1 | PERAMPANEL | 2-(2-cyanophenyl)acetic acid | 18698-99-2 |
| pyridin-2-yl acetic acid hydrochloride | 16179-97-8 |